Peter Jeffery, BSc, PgDip

GSK, United Kingdom

Disclosure(s): GSK: Complimentary Worker

Poster(s):

• (P-1879) Change in Healthcare Professional’s Identification, Counseling, and Adherence with Black Women for Long-Acting Cabotegravir (CAB LA) for PrEP Across Women’s Health, Primary Care, and Infectious Diseases Sites: Findings from the EBONI Study
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT